[Skip to Content]
[Skip to Content Landing]
Views 557
Citations 0
Comment & Response
April 2017

Increasing the Use of Lithium and Clozapine in US Suicide Prevention—Reply

Author Affiliations
  • 1Case Western Reserve University Medical School, Delmar, New York
JAMA Psychiatry. 2017;74(4):423-424. doi:10.1001/jamapsychiatry.2016.4067

In Reply In response to a Viewpoint urging action to improve suicide prevention in health care settings,1 Bastiampillai et al emphasize the effectiveness of lithium (for patients with bipolar disorder) and clozapine (for patients with schizophrenia) in reducing suicide. They note the low prescription rates of both medications in the United States and urge efforts to increase use of these effective treatments as a key suicide prevention strategy.

×